The FDA defied its own experts to approve a new prescription narcotic in a form almost certain to cause addiction and death from overdoses.
On October 26 the savvy investor’s website SeekingAlpha.com published the following remarkable comment about a new and highly addictive painkiller called Zohydro ER, which only the previous day had been approved for sale by the U.S. Food and Drug Administration despite consistent warnings – including from the FDA’s official advisory panel – that Z is potentially more addictive and dangerous than its sister opiate drug, the original and deadly OxyContin.
The full article can be read here:
Latest posts by Jeffrey Lynne (see all)
- DCF Updates Rules Regulating SUD Treatment Providers - August 14, 2019
- EMRs and the Sale of Patient Data, Part 1 - August 5, 2019
- Prosecutors bring rare criminal charges against Ohio opioid distributor - July 18, 2019